PARIS and ALACHUA, FL--(Marketwire - December 10, 2008) - Oragenics, Inc. d/b/a ONI BioPharma Inc. (NYSE Alternext US: ONI)(1), an American biopharmaceutical company that has developed broad-based technologies in oral care, antibiotics, diagnostics and weight control, announced today its additional listing on Alternext Paris. This new listing will make ONI the first US-based company to have its shares traded on Alternext Paris, beginning December 15, 2008.
